Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sightway Capital is a New York-based private equity firm that operates as a subsidiary of Pine River Capital Management. The firm specializes in making control-oriented investments in companies within the financial services and healthcare sectors, with a specific emphasis on data-driven business models. In the healthcare space, Sightway focuses on healthcare services, technology-enabled providers, and pharmaceutical services. The firm partners with experienced management teams to scale businesses through organic growth and strategic acquisitions. Their investment strategy prioritizes companies that leverage data and technology to create competitive advantages in fragmented markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sightway Capital.